Summary by Futu AI
Conning Jerry Pharmaceuticals-B (09966) filed with Hong Kong Trading and Settlement Limited on 4 January 2024 its Statement of Monthly Changes in Securities for the year ended 31 December 2023. The report shows that the company's regulary/registered share capital and issued shares were unchanged during the month, with the number of ordinary shares remaining at 25,100,000,000 shares with a face value of $0.00000002 and a total regulated/registered share capital of $50,200. The issued shares were recorded at 964,843,807 shares. In addition, the share option plan referred to in the report includes a pre- and post-IPO share option plan, but no stock options were exercised during this month and therefore no new shares were issued. The Company confirms that all issuance of securities has been authorised by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.